• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643727)   Today's Articles (2842)   Subscriber (50650)
For: Hermann C, Stern RG, Losonzcy MF, Jaff S, Davidson M. Diagnostic and pharmacological approaches in Alzheimer's disease. Drugs Aging 1991;1:144-62. [PMID: 1794010 DOI: 10.2165/00002512-199101020-00006] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Number Cited by Other Article(s)
1
The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology 2012;20:109-26. [PMID: 22535513 DOI: 10.1007/s10787-012-0130-z] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2011] [Accepted: 03/05/2012] [Indexed: 02/07/2023]
2
Prasad SBB, Kumar YCS, Kumar CSA, Sadashiva CT, Vinaya K, Rangappa KS. Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors. THE OPEN MEDICINAL CHEMISTRY JOURNAL 2007;1:4-10. [PMID: 19662135 PMCID: PMC2709467 DOI: 10.2174/1874104500701010004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/15/2007] [Revised: 07/18/2007] [Accepted: 07/31/2007] [Indexed: 11/22/2022]
3
Popović M, Caballero-Bleda M, Puelles L, Popović N. Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease. Int J Neurosci 1998;95:203-36. [PMID: 9777440 DOI: 10.3109/00207459809003341] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
4
Popović M, Caballero-Bleda M, Popović N, Bokonjić D, Dobrić S. Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer's disease in rats. Int J Neurosci 1997;92:79-93. [PMID: 9522258 DOI: 10.3109/00207459708986392] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
5
Shen ZX. The significance of the activity of CSF cholinesterases in dementias. Med Hypotheses 1996;47:363-76. [PMID: 8951800 DOI: 10.1016/s0306-9877(96)90216-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
6
Mathé G. Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects. Biomed Pharmacother 1995;49:161-7. [PMID: 7669935 DOI: 10.1016/0753-3322(96)82616-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]  Open
7
Wagstaff AJ, McTavish D. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging 1994;4:510-40. [PMID: 7521234 DOI: 10.2165/00002512-199404060-00006] [Citation(s) in RCA: 93] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
8
Aguado F, Badía A, Baños JE, Bosch F, Bozzo C, Camps P, Contreras J, Dierssen M, Escolano C, Görbig DM, Muñoz-Torrero D, Pujol MD, Simón M, Vázquez MT, Vivas NM. Synthesis and evaluation of tacrine-related compounds for the treatment of Alzheimer's disease. Eur J Med Chem 1994. [DOI: 10.1016/0223-5234(94)90039-6] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
9
Chapter 21. Alzheimer's Disease: Current Therapeutic Approaches. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 1993. [DOI: 10.1016/s0065-7743(08)60891-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
10
Kan JP, Steinberg R, Oury-Donat F, Michaud JC, Thurneyssen O, Terranova JP, Gueudet C, Souilhac J, Brodin R, Boigegrain R. SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome. Psychopharmacology (Berl) 1993;112:219-27. [PMID: 7871023 DOI: 10.1007/bf02244914] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
11
Leblhuber F, Neubauer C, Peichl M, Reisecker F, Steinparz FX, Windhager E, Dienstl E. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology (Berl) 1993;111:23-6. [PMID: 7870929 DOI: 10.1007/bf02257402] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
12
Procter AW, Francis PT, Stratmann GC, Bowen DM. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochem Res 1992;17:917-22. [PMID: 1357564 DOI: 10.1007/bf00993268] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
13
Kan JP. Current and future approaches to therapy of Alzheimer's disease. Eur J Med Chem 1992. [DOI: 10.1016/0223-5234(92)90135-n] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
14
Cholinomimetics and Alzheimer's disease. Bioorg Med Chem Lett 1992. [DOI: 10.1016/s0960-894x(00)80530-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
15
Wermuth CG, Bourguignon JJ, Hoffmann R, Boigegrain R, Brodin R, Kan JP, Soubrié P. SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome. Bioorg Med Chem Lett 1992. [DOI: 10.1016/s0960-894x(00)80540-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
16
Guiso G, Confaloneeri S, Gherardi S, Guido M, Caccia S. Liquid Chromatographic Determination of the Potential Memory Enhancing Agent CL 275,838 Using a Post-Column Photolysis and Fluorimetric Detection. ACTA ACUST UNITED AC 1992. [DOI: 10.1080/10826079208018300] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA